Special Offer: Now 25%
off original sale price of $3750
Beyond congenital and acquired immune deficiencies immunotherapy is employed in a number of major disease areas such as hypersensitivity/allergy and cancer. The application in organ transplantation dealing with prevention of allograph rejection and transplantation sickness has long been known. This report from MarketResearch.com examines this market and provides forecasts to 2005 for major immunotherapy products including:
In addition, the use of Genetic Manipulation for immunomodulation will be discussed in detail. The report will present and detail advanced research efforts. Commercial efforts and strategic alliances will be clearly presented for the specific companies profiled in the report.
For this report, the areas of advanced immunotherapy have been divided into six key segments based on application. These include:
There are some additional applications in acquired and congenital immune deficiencies, transfusion, and hematopoietic restoration and support, i.e., bone marrow transplantation, peripheral blood stem cell transplantation; however, we deem these of secondary importance to the opportunities currently presented for immunotherapy. Even within the section on autoimmune diseases, we have detailed only four specific diseases. While there are many more autoimmune disorders, many have extremely small patient populations, and other are more adequately served by current therapeutic modalities. This report focuses primarily on the applications of advanced immunotherapeutics, the options that they present, and the progress that is being made in these fields. The major market effects, with the potential of a breakthrough drug always a possibility, are expected to be long term and gradually established. Therefore, the technology trends selected in conjunction with the growing interest in immunotherapy and its expanded use present the most informative picture of advances in immunotherapeutics and the markets that result. This report covers current therapeutics, such as vaccines and immunosuppressive drugs, only in the broadest sense. It does not go into the detail of the dynamics of these various drugs in the marketplace, either branded (proprietary) or generic. It does discuss, however, the impacts that advanced immunotherapeutic technologies and applications will have on existing therapeutics markets in the whole. In general, it is the current products and technologies used in the marketplace that set the market. Immunotherapeutics will replace many of these products and technologies, but in an era of cost containment and managed care, the market value may be limited by existing standards. Market analysis for this report considers the immunotherapeutics markets in the United States. This report does not consider instrumentation, such as plasmapheresis or apheresis units, and their disposable support products. Some mention is made of therapeutic apheresis, but the specific market dynamics of that segment are not considered in detail. The focus on pharmaceutical-based technologies is further narrowed to those advanced immunotherapeutics with the potential to become first-line therapies. The analysis presented in this report is based on data from a combination of company, government, industry, institutional and private sources. It includes information from extensive literature reviews, as well as interviews and discussions with experts in the field, including immunologists, rheumatologists, pathologists, research scientists, business development managers and marketing managers. Press Release AIDS Research Benefits Immunology Market; Renewed Emphasis On Assisting Body’s Natural Healing Mechanisms New York, March 30/PRNewswire –- MarketResearch.com, the leading provider of global market intelligence, announced the release of a new research study “Current Developments in Immunotherapy Markets and Technology” from Kalorama Information. According to this study, the recognized need to aggressively combat AIDS has resulted in an unprecedented level of financial support for research in immunology and immunotherapies – research that is applicable to other immunodeficiencies like rotavirus and RSV. “The technology used to develop HIV vaccinations is based on a more thorough understanding of the human immune system, particularly cytokines,” said Richard Koulbanis, Sr. VP of Publishing for MarketResearch.com. “Once physicians understand how to use these hormonal messengers to control specific aspects of the immune system, they will be able to address the root causes of many diseases that can only be palliated today. And combined with the trend toward genetics and genomics, doctors are beginning to fight diseases on a truly individual level.” Renewed respect for the body’s natural ability to heal is just one of the key trends that will continue to push immunotherapeutics to the forefront of the pharmaceutical industry. Physicians are realizing their limitations and using immunotherapy to efficiently and effectively assist the body during the healing process. This holistic approach joins seamlessly with the second major trend – a “grass-roots” movement toward newer therapies. Through advocacy groups, medical foundations, clinics and the Internet, patients are becoming better educated about their illnesses and actively participating in their own treatment. With both patient and doctor support for new immunological approaches, immunotherapeutics may replace or influence many existing products. “Current Developments in Immunotherapy Markets and Technology” focuses primarily on the applications of advanced immunotherapeutics, the options they present and the progress being made in each field. The affect of immunotherapeutics is studied as related to cancer, rheumatoid arthritis, HIV/AIDS, autoimmune diseases, allergy, asthmas and vaccines.
Categories Covered:
Issues Addressed:
Companies/Sites Discussed:
Tables and Graphs:
Hours of Research: 700 Related Reports: McEvoy and Farmer's Complete Guide to IVD Distribution in BrazilSep 1, 2010 - KLID2765003 - $1,995.00 Emerging In Vitro Diagnostic Markets Bundle: Complete Guides to IVD Distribution in China, India, Mexico and Brazil Sep 1, 2010 - KLID2768562 - $6,995.00 McEvoy and Farmer's Complete Guide to IVD Distribution in Mexico Sep 1, 2010 - KLID2768446 - $1,995.00 The Worldwide Market for In Vitro Diagnostic Tests, 7th Edition Aug 1, 2010 - KLI2613362 - $5,995.00 [pre pub] Kalorama 2010 Ultra Diagnostics Research Bundle Jul 1, 2010 - KLI2703738 - $9,995.00 Clinical Diagnostics in India: Market Analyses and Participant Directory Jun 1, 2010 - KLI2690537 - $4,995.00 The Worldwide Market for Cancer Diagnostics, 4th Edition Apr 1, 2010 - KLI2504623 - $4,200.00 The Global Market for Medical Devices Mar 1, 2010 - KLI2592223 - $1,500.00 Lab Automation Markets, 2nd Edition (Systems, Key Companies, Forecasts and Trends) Mar 1, 2010 - KLI2601060 - $3,995.00 The Clinical Laboratory Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles) Feb 1, 2010 - KLI2565239 - $3,500.00 |
800.298.5603
Int'l: +1.240.747.3096
Questions?
Contact a research specialist >
Most Popular Research
The Global Market for Medical Devices
Medical Beds and Medical Chairs
World Wound Care Markets 2010
Clinical Nutrition Products: World Markets, 3rd Edition
Worldwide Wound Care: Total Market Coverage (Vols. I-III: Skin Ulcers, Burns, Surgical and Trauma Wounds), 4th Edition
Reusable Medical Devices and Instruments
|
||||||||||
Email a colleague
Printer format
Order by fax|
Privacy Policy
|
Terms and Conditions
|
Site Map
|
Return Policy
|
Press
|
Help FAQs
|